Back to the directory
inSoma Bio
Helping Plastic Surgeons Rebuild Fat
- Founded
- 2018
- Status
- Active
- Stage
- Early
- Team size
- 4
- Location
- Durham, NC, USA
- Category
- Biotech & Drug Discovery
- Sector
- Medical Devices
Medical DevicesSynthetic Biology
Clinical trials
1 registered trial with this company as lead sponsor, 2025.
- Status
- Suspended (1)
- Conditions
- Soft Tissue, Soft Tissue Defects, Subcutaneous Injection
Source: ClinicalTrials.gov.
Federal research funding
7 NIH awards totalling $3,390,598, FY2019 to FY2024.
- Enhancing Peripheral Nerve Repair with an Injectable Recombinant Polypeptide Scaffold
- An off the shelf alternative to fat transfer for soft tissue repair
- A recombinant elastin skin substitute for the treatment of burns
- A recombinant matrix to improve autologous tissue grafts
Source: NIH RePORTER.
Securities filings
12 Form D filings on record, 2020 to 2026.
Filed as inSoma Bio, Inc.
Source: SEC EDGAR. Form D reports an exempt offering; it does not confirm funds raised.
Company data compiled and maintained by Healthcare Discovery.
